Knut Engedal Selected Research

Activities of Daily Living (ADL)

6/2020	Characteristics of patients assessed for cognitive decline in primary healthcare, compared to patients assessed in specialist healthcare.
1/2020	Quality of life of family carers of persons with young-onset compared to late-onset dementia.
4/2019	Cortisol levels among older people with and without depression and dementia.
1/2018	Caregivers' Perspectives of Quality of Life of People With Young- and Late-Onset Alzheimer Disease.
1/2018	Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway.
1/2017	Resourse Use and Disease Couse in dementia - Nursing Home (REDIC-NH), a longitudinal cohort study; design and patient characteristics at admission to Norwegian nursing homes.
1/2015	Effect of a high-intensity exercise program on physical function and mental health in nursing home residents with dementia: an assessor blinded randomized controlled trial.
7/2014	Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia.
4/2014	A 52 month follow-up of functional decline in nursing home residents - degree of dementia contributes.
1/2014	Delirium is a risk factor for institutionalization and functional decline in older hip fracture patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Knut Engedal Research Topics

Disease

82	Dementia (Dementias) 01/2022 - 02/2002
24	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 02/2002
20	Cognitive Dysfunction 01/2022 - 01/2005
9	Stroke (Strokes) 01/2021 - 04/2006
7	Atrophy 01/2022 - 04/2012
5	Hypertension (High Blood Pressure) 01/2018 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 04/2011
4	Neoplasms (Cancer) 01/2021 - 01/2010
4	Pain (Aches) 01/2021 - 01/2017
4	Delirium 01/2017 - 07/2012
3	Disease Progression 01/2020 - 04/2012
2	Inflammation (Inflammations) 11/2021 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 04/2010
2	Mental Disorders (Mental Disorder) 08/2020 - 09/2009
2	Anxiety Disorders (Anxiety Disorder) 12/2017 - 10/2005
2	Memory Disorders (Memory Loss) 01/2017 - 12/2005
2	Fatigue 01/2016 - 07/2010
2	Xerostomia 03/2013 - 03/2013
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/2012 - 01/2009
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Hyperglycemia 06/2020
1	Insulin Resistance 06/2020
1	Tauopathies 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Osteoporosis 01/2019

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 11/2021 - 02/2002
11	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2006
8	ApolipoproteinsIBA 01/2021 - 02/2002
8	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 05/2008
8	Antidepressive Agents (Antidepressants)IBA 01/2020 - 07/2008
6	Psychotropic Drugs (Psychoactive Drugs)IBA 08/2020 - 09/2007
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2017
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021 - 02/2002
3	Interleukin-10 (Interleukin 10)IBA 11/2021 - 01/2016
3	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2019
3	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2019
3	Biological ProductsIBA 01/2017 - 10/2008
3	CholesterolIBA 01/2016 - 01/2013
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 07/2014 - 10/2005
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2020
2	Amyloid beta-PeptidesIBA 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 06/2020 - 01/2016
2	InterferonsIBA 01/2020 - 01/2016
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 04/2010
2	Pemetrexed (MTA)FDA Link 08/2018 - 04/2012
2	Pharmaceutical PreparationsIBA 01/2018 - 03/2013
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2017 - 04/2014
2	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 01/2016
2	Memantine (Namenda)FDA Link 01/2011 - 05/2005
1	Interleukin-9 (Interleukin 9)IBA 11/2021
1	Epidermal Growth Factor (EGF)IBA 11/2021
1	HomocysteineIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 06/2020
1	Insulin (Novolin)FDA Link 06/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-12 Subunit p40IBA 01/2020
1	ChemokinesIBA 01/2020
1	LigandsIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Interleukin-33IBA 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	BenzodiazepinesIBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	InterleukinsIBA 01/2020
1	amsonic acid (DAS)IBA 09/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2019
1	ReninIBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	AngiotensinsIBA 01/2019
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2019
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2019
1	chemotactic factor inactivatorIBA 01/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2017
1	EnzymesIBA 01/2017
1	Hypnotics and Sedatives (Sedatives)IBA 01/2017
1	KynurenineIBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	4-sulfoxyphenylacetyl dehydroalanine (AD 19)IBA 01/2017
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2017
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2016
1	CytokinesIBA 01/2016
1	Amino Acids FDA Link 01/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2016
1	Complement System Proteins (Complement)IBA 01/2016

Therapy/Procedure

41	Home Nursing (Nursing, Home) 05/2021 - 06/2003
25	Activities of Daily Living (ADL) 06/2020 - 10/2004
4	Medical Day Care (Partial Hospitalization) 01/2022 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 05/2005
2	Length of Stay 01/2014 - 07/2012
2	Institutionalization (Institutionalized Persons) 01/2014 - 12/2010
2	Therapeutics 06/2012 - 01/2010
2	Stroke Rehabilitation 01/2011 - 12/2010
1	Resistance Training 01/2020
1	Blood Transfusion (Blood Transfusions) 01/2017